Cargando…
抗血管药物治疗放射性脑坏死专家共识
Vascular damage is followed by vascular endothelial growth factor (VEGF) expression at high levels, which is an important mechanism for cerebral radiation necrosis (CRN) development. Antiangiogenic agents (Bevacizumab) alleviates brain edema symptoms caused by CRN through inhibiting VEGF and acting...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127755/ https://www.ncbi.nlm.nih.gov/pubmed/35570144 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.18 |
Ejemplares similares
-
晚期非小细胞肺癌抗血管生成药物治疗中国专家共识(2019版)
Publicado: (2019) -
中国肺癌脑转移诊治专家共识(2017年版)
Publicado: (2017) -
回生口服液用于非小细胞肺癌围手术期抗凝治疗专家共识(2016版)
Publicado: (2016) -
老年晚期肺癌内科治疗中国专家共识(2022版)
Publicado: (2022) -
肿瘤突变负荷应用于肺癌免疫治疗的专家共识
Publicado: (2021)